These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3599578)

  • 1. [Pharmacokinetics of rifampicin].
    Kohno H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):32-7. PubMed ID: 3599578
    [No Abstract]   [Full Text] [Related]  

  • 2. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of isoniazid, rifampicin and streptomycin in tuberculosis patients with chronic cor pulmonale].
    Petrenko VI
    Probl Tuberk; 1985; (10):34-7. PubMed ID: 4070202
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on pharmacokinetics of rifampicin in the body of patients with pulmonary tuberculosis.
    Pawlowska I; Pniewski T
    Arzneimittelforschung; 1979; 29(12):1906-11. PubMed ID: 546432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients].
    Ziia AV; Sokolov GB; Firsov AA
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):223-7. PubMed ID: 3579252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
    Eule H; Werner E; Winsel K; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
    Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
    Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of rifampin given as a single oral dose in foals.
    Castro LA; Brown MP; Gronwall R; Houston AE; Miles N
    Am J Vet Res; 1986 Dec; 47(12):2584-6. PubMed ID: 3800115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Permanent malabsorption of rifampicin in a diabetic with celiac disease].
    Dieterlen P; Cassereau H; Lestradet H
    Arch Fr Pediatr; 1986; 43(6):421-2. PubMed ID: 3778104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with endobronchial and local use of rifampicin in tuberculosis].
    Abdurashitova MV; Stoianovskiĭ EA; Fok AIa
    Probl Tuberk; 1976 Jan; (l):35-8. PubMed ID: 995905
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
    Karkishchenko NN; Vorob'ev VS; Khoron'ko VV; Anisimova NB; Chubarian VT
    Vrach Delo; 1988 Dec; (12):72-3. PubMed ID: 3245176
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin metabolism in patients with pulmonary tuberculosis].
    Pawlowska I; Pniewski T
    Gruzlica; 1975 Nov; 43(11):977-86. PubMed ID: 1193410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous rifampicin therapy in open tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
    Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin metabolism in bodies of patients with pulmonary tuberculosis. I].
    Pawlowska I; Pniewski T
    Gruzlica; 1973 Mar; 41(3):225-33. PubMed ID: 4696135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 17. On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex and of the patients.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1976; 57(1):5-11. PubMed ID: 1273544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of rifampicin and desacetylrifampicin in tuberculous patients after different rates of infusion.
    Houin G; Beucler A; Richelet S; Brioude R; Lafaix C; Tillement JP
    Ther Drug Monit; 1983; 5(1):67-72. PubMed ID: 6845401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis.
    Langdon G; Wilkins JJ; Smith PJ; McIlleron H
    Int J Tuberc Lung Dis; 2004 Jul; 8(7):862-7. PubMed ID: 15260278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.